BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 19373246)

  • 1. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
    Sun SC
    Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinases in the regulation of NF-κB signaling.
    Harhaj EW; Dixit VM
    Cell Res; 2011 Jan; 21(1):22-39. PubMed ID: 21119682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN.
    Takiuchi T; Nakagawa T; Tamiya H; Fujita H; Sasaki Y; Saeki Y; Takeda H; Sawasaki T; Buchberger A; Kimura T; Iwai K
    Genes Cells; 2014 Mar; 19(3):254-72. PubMed ID: 24461064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
    Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
    Li P; Wang Y; Turner JH
    Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
    Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
    Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
    Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
    EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.
    Draber P; Kupka S; Reichert M; Draberova H; Lafont E; de Miguel D; Spilgies L; Surinova S; Taraborrelli L; Hartwig T; Rieser E; Martino L; Rittinger K; Walczak H
    Cell Rep; 2015 Dec; 13(10):2258-72. PubMed ID: 26670046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of JNK signaling by the tumor suppressor CYLD.
    Reiley W; Zhang M; Sun SC
    J Biol Chem; 2004 Dec; 279(53):55161-7. PubMed ID: 15496400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
    Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
    EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.
    Nagabhushana A; Bansal M; Swarup G
    PLoS One; 2011 Mar; 6(3):e17477. PubMed ID: 21408173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
    Kovalenko A; Chable-Bessia C; Cantarella G; Israël A; Wallach D; Courtois G
    Nature; 2003 Aug; 424(6950):801-5. PubMed ID: 12917691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells.
    Takami Y; Nakagami H; Morishita R; Katsuya T; Hayashi H; Mori M; Koriyama H; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y
    Am J Pathol; 2008 Mar; 172(3):818-29. PubMed ID: 18245814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of NF-κB by deubiquitinases.
    Harhaj EW; Dixit VM
    Immunol Rev; 2012 Mar; 246(1):107-24. PubMed ID: 22435550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress of deubiquitinating enzyme CYLD to regulate liver-related diseases].
    Yang X; An DJ; Gao CC; Qin HY
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):477-480. PubMed ID: 31357769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
    Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYLD: a multifunctional deubiquitinase.
    Glittenberg M; Ligoxygakis P
    Fly (Austin); 2007; 1(6):330-2. PubMed ID: 18820455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD.
    Wright A; Reiley WW; Chang M; Jin W; Lee AJ; Zhang M; Sun SC
    Dev Cell; 2007 Nov; 13(5):705-716. PubMed ID: 17981138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
    Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
    J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.